Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 mg/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel]
RxNorm 1657656
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1657656 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 mg/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 mg/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 mg/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 mg/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
